Skip Nav Destination
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
Issue Archive
July 30 2009
In this Issue
Table of Contents
INSIDE BLOOD
PERSPECTIVE
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman,Jüergen Thiele,Daniel A. Arber,Richard D. Brunning,Michael J. Borowitz,Anna Porwit,Nancy Lee Harris,Michelle M. Le Beau,Eva Hellström-Lindberg,Ayalew Tefferi,Clara D. Bloomfield
CLINICAL TRIALS AND OBSERVATIONS
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Clinical Trials & Observations
Daniel M. Witt,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Thomas Delate,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Nathan P. Clark,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Chad Martell,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Thu Tran,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Mark A. Crowther,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,David A. Garcia,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Walter Ageno,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium,Elaine M. Hylek,on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
Clinical Trials & Observations
Constantine S. Tam,Tait D. Shanafelt,William G. Wierda,Lynne V. Abruzzo,Daniel L. Van Dyke,Susan O'Brien,Alessandra Ferrajoli,Susan A. Lerner,Alice Lynn,Neil E. Kay,Michael J. Keating
GENE THERAPY
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba,Angela C. Bradshaw,Alan L. Parker,David Bhella,Simon N. Waddington,Stuart A. Nicklin,Nico van Rooijen,Jerome Custers,Jaap Goudsmit,Dan H. Barouch,John H. McVey,Andrew H. Baker
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
Maite P. Quiroga,Kumudha Balakrishnan,Antonina V. Kurtova,Mariela Sivina,Michael J. Keating,William G. Wierda,Varsha Gandhi,Jan A. Burger
WT1 mutations in T-ALL
Valeria Tosello,Marc R. Mansour,Kelly Barnes,Maddalena Paganin,Maria Luisa Sulis,Sarah Jenkinson,Christopher G. Allen,Rosemary E. Gale,David C. Linch,Teresa Palomero,Pedro Real,Vundavalli Murty,Xiaopan Yao,Susan M. Richards,Anthony Goldstone,Jacob Rowe,Giuseppe Basso,Peter H. Wiernik,Elisabeth Paietta,Rob Pieters,Martin Horstmann,Jules P. P. Meijerink,Adolfo A. Ferrando
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-β and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response
Marc Remke,Stefan Pfister,Corinne Kox,Grischa Toedt,Natalia Becker,Axel Benner,Wiebke Werft,Stephen Breit,Shuangyou Liu,Felix Engel,Andrea Wittmann,Martin Zimmermann,Martin Stanulla,Martin Schrappe,Wolf-Dieter Ludwig,Claus R. Bartram,Bernhard Radlwimmer,Martina U. Muckenthaler,Peter Lichter,Andreas E. Kulozik
MYELOID NEOPLASIA
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
Ken I. Mills,Alexander Kohlmann,P. Mickey Williams,Lothar Wieczorek,Wei-min Liu,Rachel Li,Wen Wei,David T. Bowen,Helmut Loeffler,Jesus M. Hernandez,Wolf-Karsten Hofmann,Torsten Haferlach
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Holbrook E. Kohrt,Brit B. Turnbull,Kartoosh Heydari,Judith A. Shizuru,Ginna G. Laport,David B. Miklos,Laura J. Johnston,Sally Arai,Wen-Kai Weng,Richard T. Hoppe,Philip W. Lavori,Karl G. Blume,Robert S. Negrin,Samuel Strober,Robert Lowsky
VASCULAR BIOLOGY
CORRESPONDENCE
-
Cover Image
Cover Image
KC (keratinocyte-derived chemokine) stimulation induces early relocalization of endogenous Rap1 (blue) to F-actin (green)–enriched membrane ruffles, where it colocalizes with β-arrestin 2 (red). RBL-2H3 cells transiently transfected with CXCR2 and β-arrestin 2-DsRed.M1 were stimulated with KC for 1 minute, fixed, permeabilized, stained, and analyzed by confocal microscopy. See the article by Molteni et al on page 1073.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals